FDA advisers to weigh first psychedelic therapy in early June
Lilly gets a date with FDA to discuss Alzheimer's med donanemab
Sorcero genAI conjures plain language from scientific papers
How mRNA vaccines could be personalized cancer cures
*please scroll down for all the latest news*
